• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA BRONCHOFIBERVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA BRONCHOFIBERVIDEOSCOPE Back to Search Results
Model Number BF-MP160F
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Viral Infection (2248)
Date of Event 02/21/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As part of our investigation of this report, an olympus endoscopy support specialist (ess) was dispatched to the user facility to assess their reprocessing practices and to provide reprocessing training if necessary.To date, the ess visit has not been finalized.The scope is being retained at the user facility at this time.An investigation is ongoing to obtain additional information regarding the reported event.This report is to account for patient 4.This event has been reported by the importer on mdr# 2951238-2020-00371.
 
Event or Problem Description
The service center was informed that four patients contracted a cytomegalovirus infection after undergoing a procedure with the facility¿s bronchoscopes.The user facility reported that these were inpatients in the facility¿s burn or respiratory care unit.The patient samples were sent an independent laboratory and cultured positive.As a result, the user facility acquired a sample of the disinfectant flushed from the scope; however, the culture results are unknown at this.The samples from the scopes are being retained at the facility and refrigerated.The scopes were taken out service at that time; however may have been put back into service due to limited inventory.The patient¿s course of treatment is unknown.This is 7 of 8 reports.
 
Additional Manufacturer Narrative
This supplemental report is being submitted to provide additional information.Additional information from the user facility¿s microbiology supervisor states the facility worked with the local epidemiologist from georgia public health as a consult.A risk assessment was performed on these patients.From the risk assessment results these scopes have placed back in circulation months ago.The facility has implemented some extra cleaning measures.There have been no other patient infections since we completed the process.In addition, as part of our investigation, an olympus endoscopy support specialist (ess) was dispatched to the user facility to assess their reprocessing practices and to provide reprocessing training if necessary.The customer has declined this visit.
 
Additional Manufacturer Narrative
This supplemental report is being submitted to provide the lm investigation.Please see the updates in sections: g4, g7, h2, h6 and h10.The legal manufacturer (lm) reviewed the content of this complaint for further investigation.The lm reports that the root cause could not be identified since the device was not returned.The following possible causes for the reported event are presumed as follows: assumable cause1: cmv may have grown in the device due to irregularity in reprocessing method at the facility.This may have resulted in cross contamination.Assumable cause2: patient infection with cmv was caused by some factor during endoscopy at the facility.The legal manufacturer confirmed via dhr that the subject device was shipped in accordance with specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA BRONCHOFIBERVIDEOSCOPE
Common Device Name
BRONCHOFIBERVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key9816434
Report Number8010047-2020-01744
Device Sequence Number13644244
Product Code EOQ
UDI-Device Identifier04953170289064
UDI-Public04953170289064
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
K033225
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source health professional,user faci
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberBF-MP160F
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 02/24/2020
Supplement Date Received by Manufacturer07/27/2020
05/13/2021
Initial Report FDA Received Date03/11/2020
Supplement Report FDA Received Date08/20/2020
05/18/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-